Cara Therapeutics, Inc. 4
4 · Cara Therapeutics, Inc. · Filed Jun 17, 2016
Insider Transaction Report
Form 4
Lewis Michael E
Chief Scientific Advisor
Transactions
- Award
Stock Option (Right to Buy)
2016-05-04+20,000→ 20,000 totalExercise: $5.81Exp: 2026-05-04→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]The shares shall vest and become exercisable in a series of 48 successive equal monthly installments beginning on June 4, 2016, in each case subject to the reporting person's Continuous Service (as defined in the 2014 Equity Incentive Plan) as of each such date.